The Micro and The Macro.
View this email in your browser
Issue 5 June 3, 2021
RESEARCH BRIEFS
How Do Medication and Parent Training Affect ADHD in Mothers and Their Parenting Behavior?
Both medication and therapy have unique effects. Read the full summary from Russel Barkley’s adhd report below.
The striking genetically mediated risk for ADHD is such that in 25–50% of cases of children diagnosed as having ADHD, their parents may be found to have the same disorder. Past studies have clearly shown that parental ADHD has a negative impact on parenting behavior as well as on the success Research Findings (continued) of such parents in child behavior management training. Research on such dual-diagnosed ADHD families has yet to compare the impact of behavioral parenting interventions versus ADHD medications on parenting behavior and child adjustment when controlling for major confounding factors such as other treatments.
A recent journal article reported on a pilot study that compared the use of lisdexamfetamine dimesylate (LDX—brand name, Vyvanse) administered to mothers with ADHD versus the use of behavioral parent training (BPT) in families where the mother had currently untreated ADHD and the young child displayed ADHD symptoms. The study recruited 35 mothers with ADHD and their stimulant-untreated children (ages 4–8 years). The mothers were randomly assigned to receive either LDX or BPT for a period of 8 weeks. The study measures incorporated a multi-method, multi-informant approach that assessed mothers’ ADHD symptoms and current impairment, parenting behavior, and direct observations of parent–child interactions along with ratings of child ADHD symptoms and child impairment.
The findings revealed that by the eighth week, both treatments were noted to have improved mothers’ self-reported emotion regulation and mothers’ functioning (impairment). However, only the LDX medication was found to have improved mothers’ self-reported core ADHD symptoms. The medication also resulted in beneficial changes in parents’ reported ADHD symptoms as well as in their ratings of their child’s ADHD symptoms. Noteworthy is that 56% of the mothers with ADHD who had been treated with medication were “much” or “very much” improved in their ADHD, compared to just 6% of mothers who had been assigned to the BPT treatment arm.
BPT was associated with improvement in self-reported positive parenting, in parental use of inconsistent discipline, and in maternal use of corporal punishment. But so was LDX associated with improvements in maternal use of inconsistent discipline and corporal punishment. The latter findings are in keeping with earlier research on medication improvements in parenting behavior. Nevertheless, when examining the direct observations of parenting, only the BPT arm was shown to have increased positive parenting during child-directed play and cleanup along with less negative parenting during child-directed play. In contrast to the results for mothers, just 6% of children in the group whose mothers received medication were “much” or “very much” improved on the impairment measure in comparison to 35% of those whose mothers had been treated with BPT.
The authors found that both LDX and BPT produced some unique effects on maternal ADHD symptoms and parenting, but modest effects on the children. The medication was better in improving mothers’ ADHD symptoms. Yet both treatments improved mothers’ emotion regulation. Furthermore, the BPT was associated with more consistent effects on parenting using both maternal reports as well as the direct behavioral observations. Nonetheless, most children remained significantly impaired following treatment. The authors report that “combination treatment and/or longer treatment duration may be necessary to improve functioning of multiplex ADHD families.” Chronis-Tuscano, A., et al. (2020). Acute effects of parent stimulant medication versus behavioral parent training on mothers’ ADHD, parenting behavior, and at-risk children. Journal of Clinical Psychiatry.
EQUALITY
The Representation Project released its “State of The Media” report last week. The report analyzes the current state of representation of gender, race, age, disability, body size, and sexuality across ads, music, films, video games, and television. It also includes action steps to improve media representations READ IT http://therepresentationproject.org/the-state-of-media-report-2021/
1O Facts About The History of Pride Month
Cool article from Mental Floss http://therepresentationproject.org/the-state-of-media-report-2021/
The Gender Gap in Healthcare
There’s a gender data gap in health care for women, and it can have serious consequences. For example, the symptoms of a heart attack in women are written off as anxiety or ignored, and women are less likely to be prescribed pain killers but more likely to be prescribed anti-anxiety medications compared to men. Medical trials with women “are considered too complex and expensive because of fluctuations in hormone levels and the possibility of pregnancy — wrongly so, by the way.” For people of color, bias is even worse. Phoebe Kirke explores these bias and their consequences in her article, “The Bitter Pill Women Must Refuse To Swallow.” (Write Like A Girl, Medium) https://medium.com/write-like-a-girl/the-bitter-pill-women-must-refuse-to-swallow-1be7ed45d294
The Tulsa Race Massacre
One of the worst episodes of racial violence in US history. Learn about these women who preserved the story. https://www.newyorker.com/news/us-journal/the-women-who-preserved-the-story-of-the-tulsa-race-massacre
Grappling with Compassion Fatigue
What is it really and how do you help yourself? From counseling today
Long Read: To Protect Me My Parents Changed my Name without Telling Me.
“A decade later, I still struggle to balance on that hyphen—teetering on a tightrope between Asian America and Black America. My mother is from Bà Rịa. My father is from Umuhu. I am from Dallas. I am living proof of the country’s fast-changing face and a counterweight to white supremacy. As racial violence embroils the country once again, I finally understand the power of what my parents did—to not only honor the nuance of who I am, but also to hedge against the color of my dark skin.” https://www.harpersbazaar.com/culture/features/a36531532/to-protect-me-from-america-my-parents-changed-my-name-without-telling-me/?utm_source=pocket&utm_medium=email&utm_campaign=pockethits
Alternative Methods of Healing
INTERESTED IN ALTERNATIVE HEALING? I VIDEOTAPED THIS SERIES. PROVEN. EPISODE 1.
LEARN ABOUT ACCEPTANCE AND COMMITMENT THERAPY
https://contextualscience.org/wc2021virtual
2021 Virtual World Conference
ACBS is taking the World Conference online! Register your interest!
Join us to make this an unprecedented learning and networking experience.
Registration is now open for the
Virtual World Conference (24-27 June)
as well as our
Pre-Conference Workshops (12-13 June).
This year we proudly announce extensive discounts for colleagues in Developing or Low and Middle-Income Countries.
PODCAST: THE PLACEBO EFFECT
“In recent months, many of us have become familiar with the sense of fear expressing itself in our bodies. We may feel restless or physically exhausted. At times, we may even have trouble catching our breath. The deep connection between mind and body that seems so salient now was also at the center of our episode about the placebo effect. This week, we return to this 2019 story that asks what placebos might teach us about the nature of healing.” https://hiddenbrain.org/category/podcast/?s=placebo+effect
Free Online Mindfulness and Compassion Conference:
Free Online Event, June 7-13
Join 35+ presenters and explore the powerful roles mindfulness and compassion can play in life, leadership and the workplace Click here to learn more
Acute Suicidal Crises: The Suicide Risk You Might Not Know About
Webinar presented by Megan L. Rogers, PhD. The purpose of this webinar is to describe two recently proposed suicide-specific entities—Acute Suicidal Affective Disturbance and Suicide Crisis Syndrome—and highlight their research support to date and potential utility in suicide risk assessment and management
6/24/2021
When: Thursday, June 24, 2021:webinars@adaa.org Online registration is available until: 6/24/2021« Go to Upcoming Event List
Suicide risk assessment and management has traditionally relied on the disclosure of suicidal ideation to determine individuals’ current suicide risk. However, this approach has numerous limitations, including the poor specificity of suicidal ideation in leading to suicidal behavior, the fluctuating nature of suicidal ideation, and high rates of nondisclosure when suicidality is present. Additionally, traditional suicide risk assessment protocols do not provide information regarding acuity, or when suicidal behavior is likely to occur. In contrast, recently defined and validated suicide-specific entities have shown promise in characterizing acute suicidal crises and predicting imminent engagement in suicidal behavior.
The purpose of this webinar is to describe two recently proposed suicide-specific entities—Acute Suicidal Affective Disturbance and Suicide Crisis Syndrome—and highlight their research support to date and potential utility in suicide risk assessment and management. Specifically, the proposed criteria for both Acute Suicidal Affective Disturbance and Suicide Crisis Syndrome will be discussed alongside support for their factorial structure, reliability, and validity, especially in the prediction of short-term suicidal behavior.
Additionally, recommended practices of suicide risk assessment, in conjunction with established methods, will be discussed; in particular, not relying on the disclosure of suicidal ideation, and remaining vigilant to factors that may signal acute surges in suicidality, will be highlighted.
Following the identification of suicide risk, strategies for suicide risk management of these acute symptoms will also be discussed, including augmentations to safety planning, incorporating lethal means counseling, and using a multidisciplinary team to best manage risk. Finally, specific considerations with regard to patient population and specific sociodemographic characteristics will be discussed in conjunction with the utility of leveraging these approaches to understanding acute suicidal crises and risk.Learning Objectives:
Upon completion, participant will be able to list the symptoms for both Acute Suicidal Affective Disturbance and Suicide Crisis Syndrome.
Upon completion, participant will be able to describe the ways in which Acute Suicidal Affective Disturbance and Suicide Crisis Syndrome improve upon traditional suicide risk assessment in identifying those at risk for imminent suicidal behavior.
Upon completion, participant will be able to conduct a suicide risk assessment that captures both traditional and indirect/acute indicators of suicide risk.
Find out more here https://adaa.org/webinar/professional/acute-suicidal-crises-suicide-risk-you-might-not-know-about
Copyright (C) *|2021||Kristen McClure LCSW|. All rights reserved.
*|IFNOT:ARCHIVE_PAGE|**|LIST:DESCRIPTION|**|END:IF|*
Our mailing address is:
*|IFNOT:ARCHIVE_PAGE|**|HTML:LIST_ADDRESS_HTML|**|END:IF|*
Want to change how you receive these emails?
You can update your preferences or unsubscribe
*|IF:REWARDS|* *|HTML:REWARDS|* *|END:IF|*